Updates from EMBT 2021: HSCT, CAR-T and COVID-19

Christian Chabannon, MD, PhD, Institut Paoli Calmettes, Marseille, France, outlines the most exciting updates being presented at EBMT 2021, highlighting developments in the field of hematopoietic stem cell transplantation (HSCT), chimeric antigen receptor T-cell (CAR-T) therapy and the impacts of the COVID-19 pandemic on the management of patients receiving transplantation or CAR-T therapy. This interview took place during the 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2021.